IL19 and metabolic dysfunction-associated steatohepatitis: In conclusion, this is the first report that IL-19 KO mice exacerbated NASH progression, IL-19 inhibited steatosis and fibrosis by directly regulating liver metabolism, and IL-19 plays an important role in liver disease.